India to United States: Ketorolac Export Trade Route
India has recorded 645 verified shipments of Ketorolac exported to United States, representing a combined trade value of $54.2M USD. This corridor is served by 19 active Indian exporters, with an average shipment value of $84.0K USD. The leading Indian exporter is GLAND PHARMA LTD, which accounts for 26% of total export value with 152 shipments worth $14.1M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $21.6M USD in purchases. The top 3 suppliers — GLAND PHARMA LTD, ALEMBIC PHARMACEUTICALS LIMITED, GLAND PHARMA LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Ketorolac corridor is one of India's established pharmaceutical export routes, with 645 shipments documented worth a combined $54.2M USD. The route is dominated by GLAND PHARMA LTD, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's ketorolac manufacturing sector.
Across 19 active suppliers, the average shipment value stands at $84.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 29.6%, placing it at rank #6 among India's top ketorolac export destinations globally.
On the import side, key buyers of Indian ketorolac in United States include EVERSANA LIFE SCIENCE SERVICES, J KNIPPER COMPANY, BAXTER HEALTHCARE CORPORATION and 43 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 230 shipments valued at $21.6M USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portHYDERABAD ICD
Market Position
- Global rank#6
- Annual growth+29.6%
- Demand growth+24.8%
- Regulatory ease65/100
Top 10 Indian Ketorolac Exporters to United States
Showing top 10 of 19 Indian suppliers exporting Ketorolac to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLAND PHARMA LTD Avg $92.8K per shipment | 152 | $14.1M | 26.0% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED Avg $178.5K per shipment | 67 | $12.0M | 22.1% |
| 3 | GLAND PHARMA LIMITED Avg $102.7K per shipment | 116 | $11.9M | 22.0% |
| 4 | CAPLIN STERILES LIMITED Avg $53.2K per shipment | 199 | $10.6M | 19.5% |
| 5 | MICRO LABS LIMITED Avg $154.4K per shipment | 20 | $3.1M | 5.7% |
| 6 | ASPIRO PHARMA LIMITED Avg $76.7K per shipment | 14 | $1.1M | 2.0% |
| 7 | GRANULES INDIA LIMITED Avg $41.5K per shipment | 8 | $332.4K | 0.6% |
| 8 | HETERO LABS LIMITED Avg $10.6K per shipment | 30 | $316.5K | 0.6% |
| 9 | ORBION PHARMACEUTICALS PRIVATE LIMITED Avg $15.1K per shipment | 17 | $256.8K | 0.5% |
| 10 | OPTIMUS PHARMA PRIVATE LIMITED Avg $36.8K per shipment | 6 | $220.8K | 0.4% |
This table shows the top 10 of 19 Indian companies exporting ketorolac to United States, ranked by total trade value. The listed exporters are: GLAND PHARMA LTD, ALEMBIC PHARMACEUTICALS LIMITED, GLAND PHARMA LIMITED, CAPLIN STERILES LIMITED, MICRO LABS LIMITED, ASPIRO PHARMA LIMITED, GRANULES INDIA LIMITED, HETERO LABS LIMITED, ORBION PHARMACEUTICALS PRIVATE LIMITED, OPTIMUS PHARMA PRIVATE LIMITED. GLAND PHARMA LTD is the dominant supplier with 152 shipments worth $14.1M USD, giving it a 26% market share. The top 3 suppliers together account for 70% of the total trade value on this route.
Showing top 10 of 19 total Indian exporters on the India to United States Ketorolac export route.
Top 10 Ketorolac Importers in United States
Showing top 10 of 46 known buyers in United States receiving Ketorolac shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ketorolac in United States include EVERSANA LIFE SCIENCE SERVICES, J KNIPPER COMPANY, BAXTER HEALTHCARE CORPORATION, J. KNIPPER & COMPANY,, J. KNIPPER & COMPANY, among 46 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $21.6M USD across 230 shipments — representing 40% of all ketorolac imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 230 | $21.6M | 39.8% |
| 2 | J KNIPPER COMPANY | 13 | $5.5M | 10.2% |
| 3 | BAXTER HEALTHCARE CORPORATION | 93 | $5.0M | 9.2% |
| 4 | J. KNIPPER & COMPANY, | 25 | $3.1M | 5.8% |
| 5 | J. KNIPPER & COMPANY | 28 | $2.6M | 4.9% |
| 6 | EVERSANA EVERSANA | 23 | $2.6M | 4.8% |
| 7 | EVERSANA LIFE SCIENCE SERVICES, LLC | 15 | $2.4M | 4.5% |
| 8 | NORTHSTAR DISTRIBUTION CENTER | 39 | $2.1M | 3.8% |
| 9 | SOLA PHARMACEUTICALS | 20 | $1.2M | 2.2% |
| 10 | EVERSANA LIFE SCIENCE SERVICES LLC | 11 | $1.1M | 2.0% |
Showing top 10 of 46 Ketorolac importers in United States on this route.
Top 10 Ketorolac Formulations Imported by United States
Showing top 10 of 184 product formulations shipped on the India to United States Ketorolac route, ranked by trade value
United States imports a wide range of ketorolac formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML (30MG/ML) — accounts for $4.9M USD across 39 shipments. There are 184 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML (30MG/ML) | 39 | $4.9M | 9.1% |
| 2 | KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML 30MG/ML | 29 | $3.4M | 6.3% |
| 3 | KETOROLAC TROMETHAMINE INJECTION USP 60MG/2ML (30MG/ML) | 36 | $2.9M | 5.3% |
| 4 | KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML | 29 | $2.7M | 5.1% |
| 5 | KETOROLAC TROMETHAMINE INJECTION USP 30MG X 25 1ML | 21 | $2.5M | 4.6% |
| 6 | KETOROLAC TROMETHAMINE INJECTION USP 30M | 14 | $2.3M | 4.3% |
| 7 | KETOROLAC INJ USP 60MG/2ML 25 S AP USNOS | 15 | $1.8M | 3.3% |
| 8 | KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML (30MG/ML)NOS | 42 | $1.8M | 3.2% |
| 9 | KETOROLAC INJ USP 30MG/ML 25 S AP USNOS | 9 | $1.1M | 2.1% |
| 10 | KETOROLAC TROMETHAMINE INJECTION USP 60MG/2ML 30MG/ML | 7 | $1.0M | 1.9% |
Showing top 10 of 184 Ketorolac formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 67 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's ketorolac exports to United States are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LTD with 152 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GLAND PHARMA LTD, ALEMBIC PHARMACEUTICALS LIMITED, GLAND PHARMA LIMITED — together account for 70% of total trade value on this route. The average shipment value of $84.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as ketorolac tromethamine injection usp 30mg/ml 30mg/ml and ketorolac tromethamine injection usp 60mg/2ml (30mg/ml), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 230 shipments worth $21.6M USD — representing 40% of all ketorolac imports from India on this route. A total of 46 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $54.2M
- Avg. Shipment
- $84.0K
- Suppliers
- 19
- Buyers
- 46
- Transit (Sea)
- ~21 days
- Annual Growth
- +29.6%
Reverse Direction
United States → India — Ketorolac (Import)Other Ketorolac Routes
Unlock the Full India to United States Ketorolac Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 645 shipments on this route.
Frequently Asked Questions — India to United States Ketorolac Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ketorolac to United States?
The leading Indian exporters of Ketorolac to United States are GLAND PHARMA LTD, ALEMBIC PHARMACEUTICALS LIMITED, GLAND PHARMA LIMITED. GLAND PHARMA LTD holds the largest market share at approximately 26% of total trade value on this route.
Q What is the total value of Ketorolac exports from India to United States?
India exports Ketorolac to United States worth approximately $54.2M USD across 645 recorded shipments. The average value per shipment is $84.0K USD.
Q Which ports does India use to ship Ketorolac to United States?
The most active port of origin is HYDERABAD ICD with 67 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to United States for Ketorolac?
The average transit time for Ketorolac shipments from India to United States is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Ketorolac trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.6% with demand growth tracking at 24.8%. The route is ranked #6 among India's top Ketorolac export destinations globally.
Q How many suppliers are active on the India to United States Ketorolac route?
There are currently 19 active Indian suppliers exporting Ketorolac to United States. The market is moderately concentrated with GLAND PHARMA LTD accounting for 26% of total shipment value.
Q Who are the main importers of Ketorolac from India in United States?
The leading importers of Indian Ketorolac in United States include EVERSANA LIFE SCIENCE SERVICES, J KNIPPER COMPANY, BAXTER HEALTHCARE CORPORATION, J. KNIPPER & COMPANY,, J. KNIPPER & COMPANY. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 230 shipments worth $21.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Ketorolac.
- 2.Supplier/Buyer Matching: 19 Indian exporters and 46 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 645 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
645 Verified Shipments
19 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists